Clinical Trial Update: Oral Glyceryl Triacetate (GTA) in Newborns With Canavan [NA]

View source ↗

Summary

An update on a clinical trial evaluating oral glyceryl triacetate (GTA) in newborns with Canavan disease; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Canavan Disease

Drugs mentioned

• Glyceryl Triacetate (GTA) (glyceryl triacetate)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Canavan Disease | NA | Status: UNKNOWN